Innoviva, Inc. (INVA)
Total Valuation
Innoviva has a market cap or net worth of $966.75 million. The enterprise value is $1.22 billion.
Market Cap | 966.75M |
Enterprise Value | 1.22B |
Important Dates
The next estimated earnings date is Tuesday, May 7, 2024, after market close.
Earnings Date | May 7, 2024 |
Ex-Dividend Date | n/a |
Share Statistics
Innoviva has 63.23 million shares outstanding. The number of shares has decreased by -8.79% in one year.
Shares Outstanding | 63.23M |
Shares Change (YoY) | -8.79% |
Shares Change (QoQ) | -1.36% |
Owned by Insiders (%) | 1.59% |
Owned by Institutions (%) | 117.63% |
Float | 51.14M |
Valuation Ratios
The trailing PE ratio is 6.94 and the forward PE ratio is 25.81. Innoviva's PEG ratio is 0.24.
PE Ratio | 6.94 |
Forward PE | 25.81 |
PS Ratio | 3.11 |
Forward PS | 4.37 |
PB Ratio | 1.43 |
P/FCF Ratio | 6.87 |
PEG Ratio | 0.24 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 4.90, with an EV/FCF ratio of 8.67.
EV / Earnings | 6.79 |
EV / Sales | 3.93 |
EV / EBITDA | 4.90 |
EV / EBIT | 5.72 |
EV / FCF | 8.67 |
Financial Position
The company has a current ratio of 9.03, with a Debt / Equity ratio of 0.66.
Current Ratio | 9.03 |
Quick Ratio | 7.28 |
Debt / Equity | 0.66 |
Debt / EBITDA | 1.79 |
Debt / FCF | 3.17 |
Interest Coverage | 11.13 |
Financial Efficiency
Return on equity (ROE) is 29.70% and return on invested capital (ROIC) is 8.99%.
Return on Equity (ROE) | 29.70% |
Return on Assets (ROA) | 15.40% |
Return on Capital (ROIC) | 8.99% |
Revenue Per Employee | $2.77M |
Profits Per Employee | $1.60M |
Employee Count | 112 |
Asset Turnover | 0.27 |
Inventory Turnover | 0.88 |
Taxes
In the past 12 months, Innoviva has paid $14.38 million in taxes.
Income Tax | 14.38M |
Effective Tax Rate | 7.41% |
Stock Price Statistics
The stock price has increased by +34.36% in the last 52 weeks. The beta is 0.57, so Innoviva's price volatility has been lower than the market average.
Beta (1Y) | 0.57 |
52-Week Price Change | +34.36% |
50-Day Moving Average | 15.56 |
200-Day Moving Average | 14.11 |
Relative Strength Index (RSI) | 54.21 |
Average Volume (30 Days) | 685,316 |
Short Selling Information
The latest short interest is 13.02 million, so 20.59% of the outstanding shares have been sold short.
Short Interest | 13.02M |
Short Previous Month | 13.32M |
Short % of Shares Out | 20.59% |
Short % of Float | 25.46% |
Short Ratio (days to cover) | 13.86 |
Income Statement
In the last 12 months, Innoviva had revenue of $310.46 million and earned $179.72 million in profits. Earnings per share was $2.20.
Revenue | 310.46M |
Gross Profit | 267.82M |
Operating Income | 108.92M |
Pretax Income | 194.10M |
Net Income | 179.72M |
EBITDA | 248.96M |
EBIT | 213.26M |
Earnings Per Share (EPS) | $2.20 |
Balance Sheet
The company has $193.51 million in cash and $446.23 million in debt, giving a net cash position of -$252.72 million or -$4.00 per share.
Cash & Cash Equivalents | 193.51M |
Total Debt | 446.23M |
Net Cash | -252.72M |
Net Cash Per Share | -$4.00 |
Equity / Book Value | 674.96M |
Book Value Per Share | 10.68 |
Working Capital | 306.09M |
Cash Flow
In the last 12 months, operating cash flow was $141.06 million and capital expenditures -$411,000, giving a free cash flow of $140.65 million.
Operating Cash Flow | 141.06M |
Capital Expenditures | -411,000 |
Free Cash Flow | 140.65M |
FCF Per Share | $2.15 |
Margins
Gross margin is 86.27%, with operating and profit margins of 35.08% and 57.89%.
Gross Margin | 86.27% |
Operating Margin | 35.08% |
Pretax Margin | 62.52% |
Profit Margin | 57.89% |
EBITDA Margin | 80.19% |
EBIT Margin | 68.69% |
FCF Margin | 45.30% |
Dividends & Yields
Innoviva does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | 2 |
Payout Ratio | n/a |
Buyback Yield | 8.79% |
Shareholder Yield | 8.79% |
Earnings Yield | 18.59% |
FCF Yield | 14.55% |
Analyst Forecast
The average price target for Innoviva is $22.50, which is 47.74% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $22.50 |
Price Target Difference | 47.74% |
Analyst Consensus | Strong Buy |
Analyst Count | 1 |
Revenue Growth Forecast (5Y) | n/a |
EPS Growth Forecast (5Y) | n/a |
Stock Splits
The last stock split was on June 3, 2014. It was a forward split with a ratio of 1241:1000.
Last Split Date | Jun 3, 2014 |
Split Type | Forward |
Split Ratio | 1241:1000 |
Scores
Innoviva has an Altman Z-Score of 2.1 and a Piotroski F-Score of 5. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | 2.1 |
Piotroski F-Score | 5 |